Vault-13

SVB FINANCIAL GROUP

Dallas, TX · CIK 719739 · 13F filing filed 2023-11-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$53.2m reported value +0.5% vs Q2 2023
21positions
98.5%in top 10
0 new 1 added 4 reduced 3 sold out vs Q2 2023

Holdings, Q3 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 COINBASE GLOBAL INC COM CL A COIN COIN 406,973 $30.6m57.48% 57.48% UnchangedShares held: Q4 2022 407.0k, Q1 2023 407.0k, Q2 2023 407.0k, Q3 2023 407.0k
2 ROOT INC CL A NEW ROOT ROOT 783,012 $7.4m14.01% 14.01% UnchangedShares held: Q4 2022 783.0k, Q1 2023 783.0k, Q2 2023 783.0k, Q3 2023 783.0k
3 OKTA INC CL A OKTA OKTA 79,152 $6.5m12.14% 12.14% ReducedShares held: Q4 2022 112.0k, Q1 2023 99.9k, Q2 2023 99.9k, Q3 2023 79.2k -20.7k -20,720 -20.8%
4 AXSOME THERAPEUTICS INC COM AXSM AXSM 33,849 $2.4m4.45% 4.45% UnchangedShares held: Q4 2022 33.8k, Q1 2023 33.8k, Q2 2023 33.8k, Q3 2023 33.8k
5 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 35,353 $1.8m3.35% 3.35% UnchangedShares held: Q4 2022 0, Q1 2023 35.4k, Q2 2023 35.4k, Q3 2023 35.4k
6 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 127,068 $1.1m2.08% 2.08% UnchangedShares held: Q4 2022 0, Q1 2023 127.1k, Q2 2023 127.1k, Q3 2023 127.1k
7 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 16,173 $921.9k1.73% 1.73% UnchangedShares held: Q4 2022 16.2k, Q1 2023 16.2k, Q2 2023 16.2k, Q3 2023 16.2k
8 ROVER GROUP INC COM CL A COM CL A 105,534 $660.6k1.24% 1.24% UnchangedShares held: Q4 2022 105.5k, Q1 2023 105.5k, Q2 2023 105.5k, Q3 2023 105.5k
9 CAREMAX INC COM CL A COM CL A 300,000 $636.0k1.20% 1.20% UnchangedShares held: Q4 2022 300.0k, Q1 2023 300.0k, Q2 2023 300.0k, Q3 2023 300.0k
10 PLANET LABS PBC COM CL A PL PL 172,097 $447.5k0.84% 0.84% UnchangedShares held: Q4 2022 172.1k, Q1 2023 172.1k, Q2 2023 172.1k, Q3 2023 172.1k
11 GLOBAL E ONLINE LTD SHS GLBE GLBE 5,114 $203.2k0.38% 0.38% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 5.1k, Q3 2023 5.1k
12 CULLINAN THERAPEUTICS INC COM CGEM CGEM 13,516 $122.3k0.23% 0.23% UnchangedShares held: Q4 2022 27.0k, Q1 2023 20.3k, Q2 2023 13.5k, Q3 2023 13.5k
13 CARIBOU BIOSCIENCES INC COM CRBU CRBU 20,714 $99.0k0.19% 0.19% UnchangedShares held: Q4 2022 47.1k, Q1 2023 27.6k, Q2 2023 20.7k, Q3 2023 20.7k
14 GENERATION BIO CO COM COM 25,034 $94.9k0.18% 0.18% ReducedShares held: Q4 2022 52.9k, Q1 2023 40.4k, Q2 2023 27.9k, Q3 2023 25.0k -2.8k -2,848 -10.2%
15 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 10,249 $85.6k0.16% 0.16% UnchangedShares held: Q4 2022 10.2k, Q1 2023 10.2k, Q2 2023 10.2k, Q3 2023 10.2k
16 SKILLZ INC COM COM 13,950 $71.1k0.13% 0.13% AddedShares held: Q4 2022 13.7k, Q1 2023 13.7k, Q2 2023 13.7k, Q3 2023 13.9k +254 +254 1.9%
17 ALLOVIR INC COM COM 17,207 $37.0k0.07% 0.07% ReducedShares held: Q4 2022 43.0k, Q1 2023 34.4k, Q2 2023 25.8k, Q3 2023 17.2k -8.6k -8,604 -33.3%
18 MOVELLA HOLDINGS INC COM MVLA MVLA 55,528 $29.8k0.06% 0.06% UnchangedShares held: Q4 2022 0, Q1 2023 55.6k, Q2 2023 55.5k, Q3 2023 55.5k
19 VENUS CONCEPT INC COM COM 10,667 $20.9k0.04% 0.04% UnchangedShares held: Q4 2022 160.0k, Q1 2023 160.0k, Q2 2023 10.7k, Q3 2023 10.7k
20 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 13,472 $18.5k0.03% 0.03% ReducedShares held: Q4 2022 40.6k, Q1 2023 26.9k, Q2 2023 18.0k, Q3 2023 13.5k -4.6k -4,553 -25.3%
21 MOLEKULE GROUP INC COM COM 21,247 $3.1k0.01% 0.01% UnchangedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 21.2k, Q3 2023 21.2k

Sold out since Q2 2023

SecurityTickerShares held beforeValue then
DICE THERAPEUTICS INC 21,799 $1.0m21.8k shares
PARDES BIOSCIENCES INC 35,923 $65.0k35.9k shares
GREENLIGHT BIOSCIENCS HLDS P 16,950 $5.1k16.9k shares